Insite Vision Inc.  

(Public, OTCMKTS:INSV)   Watch this stock  
Find more results for insv
Nov 2 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range     -
52 week 0.12 - 0.35
Open     -
Vol / Avg. 0.00/650,138.00
Mkt cap 45.85M
P/E     -
Div/yield     -
EPS -0.10
Shares 131.95M
Beta -0.32
Inst. own 18%

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin -1693.11% 325.80%
Operating margin -1502.55% 350.38%
EBITD margin - -83.81%
Return on average assets -608.13% 280.66%
Return on average equity - -
Employees 29 -
CDP Score - -


United States - Map
+1-510-8658800 (Phone)
+1-510-8655700 (Fax)

Website links


InSite Vision Incorporated is an ophthalmic product development company that offers ophthalmic pharmaceutical products. The Company's portfolio of products is based on its DuraSite sustained drug delivery technology. The Company's offerings include BromSite and DexaSite. DuraSite sustained drug delivery technology is a synthetic polymer-based formulation to extend the residence time of a drug relative to conventional topical therapies. DuraSite enables topical delivery of a drug as a solution, gel or suspension and can be customized for delivering a variety of drug candidates. The Company is engaged in the research and development and commercial support with the DuraSite drug delivery technology for the following topical products: AzaSite, Besivance, BromSite, DexaSite, AzaSite Plus and ISV-101.